Savara Inc (SVRA) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Savara Inc   (NASDAQ: SVRA)


Savara Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Savara Inc's ROI in the second quarter of 2026?
Savara Inc recorded a cumulative net loss of $-139 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -75.52%.

Within the Healthcare sector 569 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3593 to 3919.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -1.85 % -2.27 % -2.32 % -2.98 % 21.85 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 175 206 233 124 150
Return On Investment (TTM) -75.52 % -72.59 % -69.42 % -71.18 % -58.71 %
SVRA's Overall Ranking # 3919 # 3593 # 3520 # 3624 # 3370
Seq. Investment Change TTM 3.42 % 4.19 % 5.37 % -13.55 % 2.98 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -139 -129 -119 -116 -110

SVRA Company Profile >> Back to SVRA Roi Comparisons >> See Annual SVRA Return On Investment



Return On Investment SVRA's Ranking
Within: No.
Industry # 252
Sector # 570
Overall # 3919

Return On Investment Statistics
High Average Low
102.58 %
-45.07 %
-309.44 %
(Dec 31 2013)   (Mar 31 2017)







Financial Statements
Savara Inc's II. Quarter Investments $ 175 Millions SVRA's Balance sheet
Savara Inc's II. Quarter Income $ -40 Millions Quarterly SVRA's Income Statement
SVRA's Income by Division See SVRA's Income by Division


SVRA Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 233 198 167 134 162
Y / Y Investment Growth 17.6 % 18.68 % 24.69 % -17.31 % 80.79 %
Net Income in Millions -119 -96 -55 -38 -43
Y / Y Net Income Growth - - - - -
Annual Return On Investment -50.99 % -48.39 % -32.76 % -28.49 % -26.56 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SVRA's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SVRA's Competitors
Subscribers only: Roi for Savara Inc's Suppliers
Subscribers only: Return On Investment for SVRA's Customers

Other Ratios
SVRA's Roa SVRA's Inventory Turnover Ratio SVRA's Growth Rates SVRA's Dividend Statistics
SVRA's Profitability Ratios SVRA's Asset Turnover Ratio SVRA's Dividend Growth
SVRA's Roe SVRA's Valuation Ratios SVRA's Financial Strength Ratios SVRA's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-08T22:28:39+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.